Myovant Sciences Ltd.

MYOVUnited States

26 filed reports · 404 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

$231M

FY2022 · to Mar 31, 2022

up +289% vs $59.3M

10-K

Net income

-$206M

FY2022 · to Mar 31, 2022

a year earlier: -$255M

10-K

Operating income

-$187M

FY2022 · to Mar 31, 2022

a year earlier: -$261M

10-K

Latest quarter

Revenue

$100M

Q3 FY2023 · to Dec 31, 2022

up +84.1% vs $54.4M

10-Q

Net income

-$57.6M

Q3 FY2023 · to Dec 31, 2022

a year earlier: -$63.4M

10-Q

Operating income

-$51.9M

Q3 FY2023 · to Dec 31, 2022

a year earlier: -$59.7M

10-Q

Filed reports

26 reports · Sep 2016 to Dec 2022

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR202,356Sep 2016 to Dec 2022
Annual · 10-KSEC EDGAR62,272Mar 2017 to Mar 2022

Documents

PeriodTypePeriod endPublishedFactsSource
FY2023 Q310-Q2022-12-312023-01-26312Open
FY2022 Q210-Q2022-09-302022-10-26177Open
FY2023 Q110-Q2022-06-302022-07-27198Open
FY202210-K2022-03-312022-05-11807Open
FY2022 Q310-Q2021-12-312022-01-26130Open
—10-Q2021-09-302021-10-26118Open
FY2022 Q110-Q2021-06-302021-07-28144Open
FY202110-K2021-03-312021-05-11351Open
FY2021 Q310-Q2020-12-312021-02-11140Open
FY2021 Q210-Q2020-09-302020-11-12133Open
FY2021 Q110-Q2020-06-302020-08-11137Open
FY202010-K2020-03-312020-05-18432Open

Financial data

404 concepts · 4,628 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial392 concepts · 4,383 facts · Mar 2016 to Dec 2022

  • Cash and cash equivalents at carrying value35 · Mar 2016 to Dec 2022
  • Accrued Research and Development, Current34 · Mar 2016 to Dec 2022
  • Additional paid in capital34 · Mar 2016 to Dec 2022
  • Assets34 · Mar 2016 to Dec 2022
  • Assets current34 · Mar 2016 to Dec 2022
  • Common stock par or stated value per share34 · Mar 2016 to Dec 2022
  • Common stock shares authorized34 · Mar 2016 to Dec 2022
  • Common stock shares outstanding34 · Mar 2016 to Dec 2022
  • Common stock value34 · Mar 2016 to Dec 2022
  • Liabilities34 · Mar 2016 to Dec 2022
  • Liabilities and stockholders equity34 · Mar 2016 to Dec 2022
  • Liabilities current34 · Mar 2016 to Dec 2022
  • Other assets noncurrent34 · Mar 2016 to Dec 2022
  • Prepaid expense and other assets current34 · Mar 2016 to Dec 2022
  • Property plant and equipment net34 · Mar 2016 to Dec 2022
  • Retained earnings accumulated deficit34 · Mar 2016 to Dec 2022
  • Stockholders equity (US GAAP)34 · Mar 2016 to Dec 2022
  • Common stock shares issued33 · Mar 2016 to Dec 2022
  • Comprehensive income net of tax33 · Jun 2016 to Dec 2022
  • Income tax expense benefit33 · Jun 2016 to Dec 2022
  • Increase decrease in due to related parties current33 · Jun 2016 to Dec 2022
  • Increase decrease in prepaid deferred expense and other assets33 · Jun 2016 to Dec 2022
  • Net cash provided by used in financing activities33 · Jun 2016 to Dec 2022
  • Net cash provided by used in investing activities33 · Jun 2016 to Dec 2022

Product9 concepts · 173 facts · Mar 2019 to Dec 2022

  • Revenue106 · Mar 2019 to Dec 2022
  • Revenue from collaborative arrangement excluding revenue from contract with customer30 · Mar 2020 to Dec 2022
  • Cost of goods and services sold (US GAAP)22 · Mar 2019 to Dec 2022
  • Deferred Revenue, Additions14 · Mar 2021 to Jun 2022
  • Deferred Revenue, Deductions4 · Mar 2021 to Jun 2022
  • Deferred Revenue, Imputed Interest4 · Mar 2021 to Jun 2022
  • Deferred revenue additions1 · Mar 2021
  • Deferred revenue revenue recognized11 · Mar 2021
  • Payments for Collaborative Arrangement1 · Jun 2022

Geography3 concepts · 72 facts · Mar 2017 to Mar 2022

  • Current foreign tax expense benefit24 · Mar 2017 to Mar 2022
  • Deferred foreign income tax expense benefit24 · Mar 2017 to Mar 2022
  • Income loss from continuing operations before income taxes foreign24 · Mar 2017 to Mar 2022

Segments

245 facts

Figures broken down by business line, region, product or another axis the company reports on.

Product or service15 members · 173 facts

  • Product revenue, net34 · Mar 2019 to Dec 2022
  • Collaboration expense to Pfizer20 · Mar 2019 to Jun 2022
  • Richter product supply and royalties16 · Mar 2020 to Dec 2022
  • Amortization of Regulatory Milestone14 · Mar 2020 to Dec 2022
  • Amortization of Upfront Payment14 · Mar 2020 to Dec 2022
  • License and Service14 · Mar 2019 to Dec 2022
  • MYFEMBREE14 · Mar 2020 to Dec 2022
  • ORGOVYX14 · Mar 2020 to Dec 2022
  • Pfizer collaboration revenue8 · Jun 2021 to Dec 2022
  • Accord license revenue6 · Jun 2021 to Dec 2022
  • Richter Product Supply6 · Jun 2021 to Dec 2022
  • RYEQO Royalties6 · Jun 2021 to Dec 2022
  • Cost of product revenue3 · Mar 2019 to Mar 2021
  • Accord product supply and royalties2 · Dec 2021 to Dec 2022
  • License and milestone revenue2 · Dec 2021 to Dec 2022

Statement geographicalsrt:StatementGeographicalAxis3 members · 54 facts

  • Other18 · Mar 2017 to Mar 2022
  • Switzerland18 · Mar 2017 to Mar 2022
  • United States18 · Mar 2017 to Mar 2022

Statement geographicalus-gaap:StatementGeographicalAxis3 members · 18 facts

  • Other6 · Mar 2017 to Mar 2018
  • Switzerland6 · Mar 2017 to Mar 2018
  • United States6 · Mar 2017 to Mar 2018

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of Myovant Sciences Ltd. (MYOV) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.